Search
for
Sort by
Research 661–690 of 1000+
- Dermatologic Reactions to Targeted Therapy
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Inhibition of Established Tuberculin Hypersensitivity by Methptrexate,
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Dermatologic manifestations of endocrine disorders
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children
- Diagnosis of common, benign neonatal dermatoses
- Head and Neck Reconstruction
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Hereditary Hypotrichosis and Localized Morphea: A New Clinical Entity
- Acne
- Skin manifestations of endocrine diseases
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- The eosinophilia-myalgia syndrome
- A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Congenital Combined Melanocytic Nevus of the Scalp With Associated Alopecia Areata
- Pulmonary arterial aneurysm in Behçet's disease
- Conceptual Basis for Use of Chemotherapeutic Agents and Their Pharmacology
- Update on Frontal Fibrosing Alopecia
- Facial Psoriasis Log-based Area and Severity Index: A valid and reliable severity measurement method detecting improvement of facial psoriasis in clinical practice settings
- Atlas of Geriatric Dermatology
- Thyroid Autoimmunity in Patients with Skin Disorders
- Acne and acneiform eruptions
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- Biological effects of human placental extracts - variations in manufacturing methods and compositions
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Cutaneous drug reactions